Email This Press Releases

CEL-SCI CSO Dr. Eyal Talor Published in European Biopharmaceutical Review Spring 2014 Edition

CorporateProfile.com recently reported a story on CEL-SCI Corporation, a biotech company dedicated to improving the treatment of cancer and other diseases by utilizing the body's natural immune defense system.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy